← Back
$ARQT All transactions

Arcutis Biotherapeutics, Inc.

M 10b5-1 Plan

$ Value

$0

Shares

10,000

Price

$0

Filed

Sep 4

Insider

Name

Welgus Howard G.

Title

CIK

0001801050

Roles

Director

Transaction Details

Transaction Date

2025-09-02

Code

M

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

Footnotes

The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted on March 11, 2025, by the Reporting Person, with a plan end date of May 29, 2026. | The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $15.45 to $15.81, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. | This option is fully vested.

Filing Info

Accession No.

0001787306-25-000132

Form Type

4

Issuer CIK

0001787306

Welgus Howard G.'s History

Date Ticker Type Value
2026-04-01 ARQT $239K
2026-03-02 ARQT $257K
2026-02-02 ARQT $250K
2026-01-02 ARQT $290K
2025-12-01 ARQT $302K
2025-11-03 ARQT $253K
2025-10-01 ARQT M $16K
2025-10-01 ARQT $180K
2025-10-01 ARQT $9K
2025-10-01 ARQT M $0

Other Insiders at ARQT (90d)

Insider Bought Sold Last
Leonard Keith R $997K 2026-03-02
Burnett Patrick
See Remarks
$505K 2026-03-02
Matsuda Masaru
See Remarks
$1.3M 2026-03-02
Welgus Howard G. $746K 2026-04-01
Watanabe Todd
See Remarks
$1.4M 2026-03-02
Edwards Larry Todd
See Remarks
$145K 2026-03-02
Vairavan Latha
SVP Chief Financial Officer
$106K 2026-03-02